| Dr James Richard Alaly, MD | |
|
120 E Beauregard Ave, San Angelo, TX 76903-5919 | |
| (325) 747-1511 | |
| Not Available |
| Full Name | Dr James Richard Alaly |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 120 E Beauregard Ave, San Angelo, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669616421 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | P6313 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Shannon Medical Center | San angelo, TX | Hospital |
| Ballinger Memorial Hospital | Ballinger, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shannon Clinic | 0840103727 | 412 |
News Archive
New data presented at the International Liver Congress 2012 shows consolidation of the interferon-free (IFN) revolution in HCV treatment. The much anticipated data from a number of clinical trials confirm that combinations of antivirals offer the hope of shorter, more effective treatment with fewer side effects.
Researchers from UCLA's cancer and stem cell centers have demonstrated for the first time that blood stem cells can be engineered to create cancer-killing T-cells that seek out and attack a human melanoma. The researchers believe this approach could be useful in 40 percent of Caucasians with this malignancy.
"The African Union has launched a new website for its Campaign on Accelerated Reduction of Maternal, Newborn and Child Mortality in Africa (CARMMA)," which "aims to promote maternal and newborn survival, and provide evidence on progress to achieving health targets that have been set by African leaders," according to the Maternal Health Task Force's blog.
If you're older, a woman, and suffering from either dementia or diabetes, you are the most likely to be exposed to unsubsidized medication costs in the US. This is known as the coverage gap for enrollees of Medicare Part D - the US federal program which subsidizes the cost of prescription drugs for Medicare beneficiaries.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.
› Verified 7 days ago
| Entity Name | Shannon Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770587149 PECOS PAC ID: 0840103727 Enrollment ID: O20031222000702 |
News Archive
New data presented at the International Liver Congress 2012 shows consolidation of the interferon-free (IFN) revolution in HCV treatment. The much anticipated data from a number of clinical trials confirm that combinations of antivirals offer the hope of shorter, more effective treatment with fewer side effects.
Researchers from UCLA's cancer and stem cell centers have demonstrated for the first time that blood stem cells can be engineered to create cancer-killing T-cells that seek out and attack a human melanoma. The researchers believe this approach could be useful in 40 percent of Caucasians with this malignancy.
"The African Union has launched a new website for its Campaign on Accelerated Reduction of Maternal, Newborn and Child Mortality in Africa (CARMMA)," which "aims to promote maternal and newborn survival, and provide evidence on progress to achieving health targets that have been set by African leaders," according to the Maternal Health Task Force's blog.
If you're older, a woman, and suffering from either dementia or diabetes, you are the most likely to be exposed to unsubsidized medication costs in the US. This is known as the coverage gap for enrollees of Medicare Part D - the US federal program which subsidizes the cost of prescription drugs for Medicare beneficiaries.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Richard Alaly, MD Po Box 22000, San Angelo, TX 76902-7200 Ph: (325) 747-1511 | Dr James Richard Alaly, MD 120 E Beauregard Ave, San Angelo, TX 76903-5919 Ph: (325) 747-1511 |
News Archive
New data presented at the International Liver Congress 2012 shows consolidation of the interferon-free (IFN) revolution in HCV treatment. The much anticipated data from a number of clinical trials confirm that combinations of antivirals offer the hope of shorter, more effective treatment with fewer side effects.
Researchers from UCLA's cancer and stem cell centers have demonstrated for the first time that blood stem cells can be engineered to create cancer-killing T-cells that seek out and attack a human melanoma. The researchers believe this approach could be useful in 40 percent of Caucasians with this malignancy.
"The African Union has launched a new website for its Campaign on Accelerated Reduction of Maternal, Newborn and Child Mortality in Africa (CARMMA)," which "aims to promote maternal and newborn survival, and provide evidence on progress to achieving health targets that have been set by African leaders," according to the Maternal Health Task Force's blog.
If you're older, a woman, and suffering from either dementia or diabetes, you are the most likely to be exposed to unsubsidized medication costs in the US. This is known as the coverage gap for enrollees of Medicare Part D - the US federal program which subsidizes the cost of prescription drugs for Medicare beneficiaries.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.
› Verified 7 days ago
Dr. James L Studt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 102 N Magdalen St, Suite 120, San Angelo, TX 76903 Phone: 325-653-2010 Fax: 325-658-8583 | |
Eddie G Shell Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 120 E Beauregard Ave, San Angelo, TX 76903 Phone: 325-658-1511 | |
Dr. Kenneth Anderson Taylor, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 120 E Beauregard Ave, San Angelo, TX 76903 Phone: 325-658-1511 Fax: 325-481-2165 | |
Michael G Sickels, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 120 E Beauregard Ave, San Angelo, TX 76903 Phone: 325-658-1511 | |
John E Alexander, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3308 Foster St, San Angelo, TX 76903 Phone: 325-658-3576 Fax: 325-658-7737 | |
Dr. Liem Thanh Mansfield, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 120 E Beauregard Ave, San Angelo, TX 76903 Phone: 325-747-1511 | |
Victor H Gil, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 120 E Beauregard Ave, San Angelo, TX 76903 Phone: 325-658-1511 |